Bristol Myers Squibb · 7 hours ago
Vice President, General Manager & Site Head, Indianapolis
Bristol Myers Squibb is a dynamic biotechnology company focused on improving survival of people with cancer. The Vice President, General Manager & Site Head will lead the radiopharmaceutical commercial/clinical manufacturing facility in Indianapolis, ensuring operational excellence and regulatory compliance while driving strategic direction and talent management.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Set strategic direction for the Indianapolis site
Set tactical direction to ensure completion of critical objectives
Lead the manufacturing organization to ensure commercial readiness
Responsible for preparation, review, and approval of budgetary plans, including production efficiency metrics, financial reporting and capital expenditure submissions
Build and recruit strong cross-functional teams across all operational disciplines
Establish critical KPIs, monitor progress and keep stakeholders informed of status
Drive continuous improvement programs to ensure operational excellence and GMP compliance
Ensure the site’s operational teams meet demand and on-time delivery objectives
Promote a ‘safety-first’ culture and ensure an injury-free work environment that protects employees from all hazards by implementation of strong controls
Lead and ensure successful federal and local health authority inspections
Qualification
Required
BS degree required
Minimum 15 years of relevant experience required, preferably in radiopharmaceutical or sterile injectable manufacturing operations
Minimum 10 years of leadership and management experience
Experience developing and managing budgets to meet corporate objectives
Knowledge and experience of regulatory processes, GMP, EHS and experience dealing with capital investment and fiscal management processes
Proven leadership and experience building and leading multidisciplinary teams in GMP pharmaceutical environments
Strong people skills and high emotional intelligence
Risk based decision making and budgetary discipline
Ability to manage time and resources effectively
Preferred
Advanced degree preferred
Multi-site / multi-country experience is preferable
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Recent News
2026-01-25
The Motley Fool
2026-01-24
Company data provided by crunchbase